Skip to content
AiONAiON

Articles

Medical evidence, explained so you can decide about your health.

Medical guides by treatment

All guides, newest first

Testosterona en gel vs inyectable: qué cambia según la vía de administración

Testosterone gel vs injection: what changes depending on the route of administration

The route a drug takes into the body changes how much of it reaches the bloodstream, and how fast. Here we explain what bioavailability is, why the route matters, and what the evidence says about the idea that injections are always "stronger".

05 Aug 2026
Read more about Testosterone gel vs injection: what changes depending on the route of administration
Suplementos para el pelo (biotina, saw palmetto…): qué funciona y qué no

Hair supplements (biotin, saw palmetto…): what works and what does not

Biotin, hair complexes, plant extracts: every month a new bottle appears promising to stop hair loss. We look at what the evidence really says, what effect nutraceuticals have and why biotin can give you a scare on a blood test.

04 Aug 2026
Read more about Hair supplements (biotin, saw palmetto…): what works and what does not
Alopecia areata: qué es y en qué se diferencia de la caída común

Alopecia areata: what it is and how it differs from common hair loss

Alopecia areata is not the same as ordinary balding. We explain what defines it, why it happens, how it is diagnosed and how it differs from androgenetic alopecia, based on the evidence available today.

03 Aug 2026
Read more about Alopecia areata: what it is and how it differs from common hair loss
Prediabetes: qué es y cómo se aborda

Prediabetes: what it is and how it is managed

Prediabetes is not an established disease, but a state of risk. We explain what the numbers mean, why it matters beyond blood sugar and what the evidence says about how to manage it.

03 Aug 2026
Read more about Prediabetes: what it is and how it is managed
Sequedad vaginal y dolor en las relaciones: la menopausia de la que no se habla

Vaginal dryness and painful sex: the side of menopause nobody talks about

Vaginal dryness and pain during sex are common symptoms after the menopause and form part of what is known as genitourinary syndrome. We explain why it happens, what the evidence says and why effective treatment exists even though many women never seek help.

03 Aug 2026
Read more about Vaginal dryness and painful sex: the side of menopause nobody talks about
Terapia con testosterona (TRT): qué es, cómo se administra y qué esperar

Testosterone replacement therapy (TRT): what it is, how it is given and what to expect

What testosterone therapy really is, who it is indicated for, how it is prescribed in Spain and what the evidence says about its benefits and its risks, without the hype or the anti-ageing promises.

03 Aug 2026
Read more about Testosterone replacement therapy (TRT): what it is, how it is given and what to expect
Terapia hormonal de la menopausia (THS): qué es, para quién y sus riesgos reales

Menopausal hormone therapy (HRT): what it is, who it's for and its real risks

For twenty years, a single study from 2002 frightened an entire generation of women and their doctors. We now know its findings were misread. Here's what menopausal hormone therapy really is, who it makes sense for and what its real risks are, with the figures on the table and the nuances that go with them.

31 Jul 2026
Read more about Menopausal hormone therapy (HRT): what it is, who it's for and its real risks
Recuperar el peso tras dejar el tratamiento: por qué pasa y cómo se maneja

Weight regain after stopping treatment: why it happens and how it is managed

Regaining some weight after stopping a GLP-1 receptor agonist is an expected physiological phenomenon, not a failure of willpower. We explain what the evidence from the semaglutide and tirzepatide trials shows, what comes back and what doesn't, and where things stand in Spain.

29 Jul 2026
Read more about Weight regain after stopping treatment: why it happens and how it is managed
Testosterona baja (hipogonadismo): síntomas reales y cuándo preocuparse

Low testosterone (hypogonadism): the symptoms that actually matter and when to worry

Low testosterone has become a catch-all explanation for tiredness or low mood, but genuine hypogonadism is something else: it requires specific symptoms plus a confirmed blood test, and it is less common than the marketing suggests. Here is what the evidence says, which symptoms really count, and why a single low reading diagnoses nothing.

27 Jul 2026
Read more about Low testosterone (hypogonadism): the symptoms that actually matter and when to worry
Baricitinib and JAK inhibitors: the new treatment for alopecia areata

Baricitinib and JAK inhibitors: the new treatment for alopecia areata

Baricitinib (Olumiant) is the first systemic drug authorised in Spain for severe alopecia areata: in adults and in adolescents aged 12 and over, and publicly funded in adults. Here is what it is, what the trials found and where the caveats lie.

24 Jul 2026
Read more about Baricitinib and JAK inhibitors: the new treatment for alopecia areata
Finasterida para la caída del pelo: cómo funciona, resultados y efectos

Finasteride for hair loss: how it works, results and side effects

Finasteride is one of the treatments authorised in Spain for androgenetic alopecia in men. We explain how it acts on DHT, what the trials show, which side effects the EMA has been monitoring since 2025 and why the decision is always an individual medical assessment.

24 Jul 2026
Read more about Finasteride for hair loss: how it works, results and side effects
Fezolinetant (Veoza): the new non-hormonal pill for hot flushes

Fezolinetant (Veoza): the new non-hormonal pill for hot flushes

Veoza is the first non-hormonal medicine authorised in Spain for moderate to severe menopausal hot flushes. What it is, what the SKYLIGHT trials found and why it requires liver monitoring.

22 Jul 2026
Read more about Fezolinetant (Veoza): the new non-hormonal pill for hot flushes

It's time to reach your goal.

Online medical assessment, prescription when appropriate and 1:1 follow-up with this team.

Start assessment